<DOC>
	<DOCNO>NCT01064076</DOCNO>
	<brief_summary>This clinical study design evaluate safety effectiveness subcutaneous implantable defibrillator ( S-ICD ) System .</brief_summary>
	<brief_title>S-ICD® System IDE Clinical Study</brief_title>
	<detailed_description>This clinical study prospective , non-randomized , multicenter clinical study without control group conduct United States , Europe , New Zealand . Patients meet eligibility criterion implant S-ICD System enrol clinical study , implant S-ICD System , follow prior hospital discharge , post-implant 30 day , 90 day , 180 day . After 180-day post-implant follow-up visit , patient continue follow semi-annually study closure . Eligible patient enrol clinical study may also participate chronic conversion sub-study . The safety endpoint evaluate use 180-day S-ICD System complication-free rate . The effectiveness endpoint evaluate use induced ventricular fibrillation ( VF ) conversion efficacy rate . Spontaneous episodes chronic conversion test data evaluate use descriptive statistic provide additional data support continued chronic performance S-ICD System .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>For patient without exist transvenous device • Patient meet Class I , Class IIa Class IIb indications/recommendations ICD implantation per current publish guideline time enrollment For patient exist transvenous device • Patient require replacement revision exist implant transvenous ICD system Age ≥ 18 year An appropriate preoperative ECG per template provide Any condition precludes subject 's ability comply study requirement , include completion study . Females pregnant lactate premenopausal woman unwilling use adequate birth control duration study . Participation investigational study without prior write consent study sponsor . Patients serious medical condition life expectancy le one year . Patients document spontaneous frequently recur VT reliably terminate antitachycardia pacing , unless patient candidate transvenous ICD system . Patients exist epicardial patch subcutaneous electrode leave thoracic quadrant . Patients unipolar pacemaker implant device revert unipolar pacing . Patients severely impaired kidney function measure CockcroftGault Glomerular Filtration Rate ( GFR ) estimate GFR ≤ 29 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>ICD , defibrillator</keyword>
</DOC>